Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy

Digestive Diseases and Sciences

Volumn 56, Issue 10, 2011, Pages 2871-2878

  Roorda, Andrew K ^a   Marcus, Samuel N ^c   Triadafilopoulos, George ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c El Camino GI Medical   (United States)

Author keywords

Dyspepsia; Endoscopy; Esophageal motility; Esophageal pH monitoring; Gastroesophageal reflux disease

Indexed keywords

PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; BARRETT ESOPHAGUS; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE SEVERITY; DYSPHAGIA; EPIGASTRIC PAIN; ESOPHAGITIS; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HIATUS HERNIA; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; NON EROSIVE REFLUX DISEASE; OUTPATIENT; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX LIKE DYSPEPSIA; SCORING SYSTEM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; ESOPHAGEAL PH MONITORING; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTON PUMP INHIBITORS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054719454     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1708-9     Document Type: Article

References (20)

1. J Tack NJ Talley M Camilleri, et al. 2006 Functional gastroduodenal disorders Gastroenterology 130 1466 1479 16678560 10.1053/j.gastro.2005.11.059
2. Chronic Disease Epidemiology and Control Section, Department of Health Services, Sacramento, California 94234-7320, USA.
3. P Moayyedi J Duffy B Delaney 2004 New approaches to enhance the accuracy of the diagnosis of reflux disease Gut 53 iv55 iv57 15082616 10.1136/gut.2003.034363 (Pubitemid 38580762)
4. Management of dyspepsia: Report of a working party. Lancet. 1988;1:576-579.
5. NJ Talley V Stanghellini RC Heading, et al. 1999 Functional gastroduodenal disorders Gut 45 II37 II42 10457043 10.1136/gut.45.2008.ii37
6. AB Thomson AN Barkun D Armstrong, et al. 2003 The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study Aliment Pharmacol Ther 17 1481 1491 12823150 10.1046/j.1365-2036.2003.01646.x 1:STN:280:DC%2BD3s3psFOnug%3D%3D (Pubitemid 36831439)
7. P Moayyedi NJ Talley MB Fennerty, et al. 2006 Can the clinical history distinguish between organic and functional dyspepsia? JAMA 295 1566 1576 16595759 10.1001/jama.295.13.1566 1:CAS:528:DC%2BD28Xjt12it7w%3D
8. Savary M, Miller G. Manuel et Atlas d' Endoscopie. Solothurn (Switzerland): Verlag Gassmann, 1977.
9. J Dent J Brun AM Fendrick, et al. 1999 An evidence-based appraisal of reflux disease management-the Genval Workshop Report Gut 44 S1 S16 10.1136/gut.44.2008.S1
10. LB Gerson V Boparai N Ullah G Triadafilopoulos 2004 Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors Aliment Pharmacol Ther 20 637 643 15352912 10.1111/j.1365-2036.2004.02127.x 1:CAS:528: DC%2BD2cXovVyltL8%3D (Pubitemid 39279052)
11. F Ismail-Beigi PF Horton CE Pope 2nd 1970 Histological consequences of gastroesophageal reflux in man Gastroenterology 58 163 174 5413015 1:STN:280:DyaE3c7gsFWnug%3D%3D
12. DJ Bowery GT Williams GW Clark 2003 Histological changes in the oesophageal squamous mucosa: Correlation with ambulatory 24 hour pH monitoring J Clin Pathol 56 205 208 10.1136/jcp.56.3.205 (Pubitemid 36308036)
13. G Triadafilopoulos T Castillo 1991 Nonpropulsive esophageal contractions and gastroesophageal reflux Am J Gastroenterol 86 153 159 1992626 1:STN:280:DyaK3M7islCmtQ%3D%3D
14. LF Johnson TR Demeester 1974 Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux Am J Gastroenterol 62 325 332 4432845 1:STN:280:DyaE2M%2Flt1WmtQ%3D%3D
15. RJ Laheij RW De Koning AM Horrevorts, et al. 2004 Predominant symptom behavior in patients with persistent dyspepsia during treatment J Clin Gastroenterol 38 490 495 15220683 10.1097/01.mcg.0000123164.86324.24 (Pubitemid 38808421)
16. V Meineche-Schmidt T Jorgensen 2002 Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia Dig Liver Dis 34 332 338 12118950 10.1016/S1590-8658(02)80126-8 1:STN:280:DC%2BD38zntlCqsg%3D%3D (Pubitemid 34546213)
17. M Heikkinen M Farkkila 2003 What is the long-term outcome of the different subgroups of functional dyspepsia? Aliment Pharmacol Ther 18 223 229 12869083 10.1046/j.1365-2036.2003.01685.x 1:STN:280:DC%2BD3szjs1yntg%3D%3D (Pubitemid 36951659)
18. V Meineche-Schmidt 2004 Classification of dyspepsia and response to treatment with proton-pump inhibitors Aliment Pharmacol Ther 20 1171 1179 15569120 10.1111/j.1365-2036.2004.02243.x 1:STN:280:DC%2BD2crpsFGgsw%3D%3D (Pubitemid 39657951)
19. WM Wong BC Wong WK Hung, et al. 2002 Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients Gut 51 502 506 12235071 10.1136/gut.51.4.502 1:CAS:528:DC%2BD3sXhslWmtrk%3D
20. NJ Talley 2004 What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia Aliment Pharmacol Ther 20 23 30 15335410 10.1111/j.1365-2036.2004.02043.x (Pubitemid 39237525)